- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
MediciNova Inc+ Add to Watchlist
MNOV:US3.8200 USD 0.0600 1.55%
As of 20:10:00 ET on 05/01/2015.
Company Profile for MediciNova Inc (MNOV)
MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. The Company, through alliances with Japanese pharmaceutical companies, has built a portfolio of drug candidates. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.
Key Executives for MediciNova Inc (MNOV)
|Yuichi IwakiPresident/CEO/Founder||Van Den BoomChief Financial Officer|
|Kazuko MatsudaChief Medical Officer||Masatsune OkajimaVP/Head:Japanese Office|
|Geoffrey G O'BrienVice President|